Built for the front desk,
not the specialist's room.
POLI quantifies macular sensitivity in two minutes flat. The first front-desk instrument cleared for early AMD, grounded in published photoreceptor research.
A clinical instrument,
not a consumer gadget.
Brushed-aluminum base,
faceted matte chassis.
Compact tabletop form factor.
Twin binocular eyepieces.
Designed to sit beside the slit lamp,
not replace it.
Three claims. Each one earned.
Every line below is followed by the evidence. The promise comes second to the proof. Click any of them to read the underlying work.
What POLI measures, and why
the metric matters.
Standard imaging tools, like OCT, take a structural picture of the retina. They show what the tissue looks like. They do not show what it is doing. By the time damage is visible on imaging, photoreceptors have already died.
POLI takes a functional measurement instead. It quantifies macular sensitivity, the threshold at which photoreceptors respond to controlled light stimuli. A decline in macular sensitivity precedes structural change by years. STUB · pending exact clinical wording
The output is a single, defensible number, comparable across visits and across patients. The number is what gives the clinician triage confidence.
A full test in under two minutes.
Speed only matters if it does not cost accuracy. POLI is designed around a workflow real clinics can absorb without restructuring their schedule.
Patient seated
Standard exam chair. No special positioning. No drops.
~ 20sBoth eyes measured
Stimuli sequence runs automatically across both eyes. Patient responds with a single button.
~ 90s, both eyesReadout printed
A single macular sensitivity score, ready for triage. Goes into the patient chart.
~ 10sTotal chair time, both eyes: under 2 minutes.
What Class I means for a clinic.
- Same risk category as standard ophthalmic instruments. Tonometers, ophthalmoscopes, slit lamps. POLI sits in the same class.
- No new training or certification. Any trained optometric assistant can run the test. No specialist sign-off required.
- No incremental liability footprint. POLI does not change the legal profile of your practice. It does not introduce risk your existing instruments do not already carry.
- Faster to clinic floor. Class I devices follow general controls under the FDA and Health Canada, which is why POLI ships to clinics in 2026, not 2028.
Class I, the customer-side argument.
The Class I designation is not a regulatory footnote for clinicians. It is the reason POLI lands in a clinic the same way a new slit lamp would, not the way an investigational device would.
For a clinic owner deciding whether to bring a new instrument into the practice, the question that matters is: does this fit the way I already work? Class I is the short answer.
Selected publications.
POLI builds on published research in retinal function and macular sensitivity. These are the papers that ground the measurement.
Quantifying macular sensitivity in early AMD
Retinal photometric biomarkers as early indicators of age-related macular degeneration.
Sub-clinical macular signal capture
A method for detecting functional photoreceptor loss before structural change is visible on OCT.
Front-desk AMD screening, a clinical pathway
How a sub-minute measurement reshapes the optometrist's triage decision for early intervention.
Built for the
modern clinic.
A single instrument that puts a defensible early-AMD readout on every patient's chart, in under two minutes, without specialist supervision.
- Quantified macular sensitivity
- Class I medical device
- Under two minutes, both eyes
- No drops, no dilation
- One-button patient response
- Fits beside your slit lamp
Bring POLI to
your clinic.
Tell us about your practice. We will follow up with pilot details, or reach our team directly using the addresses to the right.